INVITRO PARAMETERS WHICH MAY PREDICT CLINICAL-RESPONSE OF CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL) TO DEOXYCOFORMYCIN (DCF)

被引：0
|
作者：
YU, AL [1 ]
QIAO, CN [1 ]
DILLMAN, RO [1 ]
MATSUMOTO, SS [1 ]
机构：
[1] UNIV CALIF SAN DIEGO,SAN DIEGO,CA 92103
来源：
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH | 1986年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：196 / 196
页数：1
相关论文
共 50 条
  • [41] VERAPAMIL INHIBITS B-CELL PROLIFERATION AND TUMOR-NECROSIS-FACTOR RELEASE AND INDUCES A CLINICAL-RESPONSE IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA
    BERREBI, A
    SHTALRID, M
    KLEPFISH, A
    BASSOUSGUEDJ, L
    KUSHNIR, M
    SHULMAN, L
    HAHN, T
    EXPERIMENTAL HEMATOLOGY, 1993, 21 (08) : 1089 - 1089
  • [42] VERAPAMIL INHIBITS B-CELL PROLIFERATION AND TUMOR-NECROSIS-FACTOR RELEASE AND INDUCES A CLINICAL-RESPONSE IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA
    BERREBI, A
    SHTALRID, M
    KLEPFISH, A
    BASSOUS, L
    KUSHNIR, M
    SHULMAN, L
    VORST, E
    HAHN, T
    LEUKEMIA, 1994, 8 (12) : 2214 - 2216
  • [43] RESPONSE TO HIGH-DOSE METHYLPREDNISOLONE IN END-STAGE CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL) PATIENTS SUGGESTED BY DISC ASSAY
    BOSANQUET, AG
    MCCANN, SR
    CROTTY, GM
    MILLS, MJ
    BRITISH JOURNAL OF HAEMATOLOGY, 1993, 84 : 41 - 41
  • [44] EPSTEIN-BARR-VIRUS (EBV) INFECTED CLONE IN THE LEUKEMIA-CELL POPULATION OF A CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL) PATIENT WITH PROLIFERATIVE ADVANTAGE INVITRO BUT NOT INVIVO
    LEWIN, N
    EHLINHENRIKSSON, B
    MINAROVITS, J
    MELLSTEDT, H
    KLEIN, E
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1990, 32 (04) : 402 - 402
  • [45] CORRELATION OF SERUM-PROTEIN ELECTROPHORESIS (SPEP) PATTERNS AND OTHER CLINICAL CHARACTERISTICS OF 98 CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL) PATIENTS
    MILLER, RH
    LINET, MS
    VANATTA, ML
    MCCAFFREY, LD
    HUMPHREY, RL
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1986, 27 : 194 - 194
  • [46] CLINICAL AND HEALTH-STATUS ASSESSMENTS IN ANEMIC CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL) PATIENTS TREATED WITH EPOETIN-ALFA (EPO)
    ROSE, E
    RAI, K
    REVICKI, D
    BROWN, R
    REBLANDO, J
    BLOOD, 1994, 84 (10) : A526 - A526
  • [47] Stage 0 B-cell chronic lymphocytic leukemia (CLL): Clinical factors to predict disease progression.
    Callea, V
    Iacopino, P
    Princi, D
    Caridi, C
    Tebala, D
    Stelitano, C
    Nobile, F
    Morabito, F
    Jaksic, B
    Brugiatelli, M
    BLOOD, 2000, 96 (11) : 272B - 272B
  • [48] PROGNOSTIC FACTORS IN CHRONIC LYMPHOCYTIC-LEUKEMIA - THE IMPORTANCE OF AGE, SEX AND RESPONSE TO TREATMENT IN SURVIVAL - A REPORT FROM THE MRC CLL 1 TRIAL
    CATOVSKY, D
    FOOKS, J
    RICHARDS, S
    BRITISH JOURNAL OF HAEMATOLOGY, 1989, 72 (02) : 141 - 149
  • [49] RESPONSE ASSESSMENT IN CHRONIC LYMPHOCYTIC-LEUKEMIA AFTER FLUDARABINE PLUS PREDNISONE - CLINICAL, PATHOLOGICAL, IMMUNOPHENOTYPIC, AND MOLECULAR ANALYSIS
    ROBERTSON, LE
    HUH, YO
    BUTLER, JJ
    PUGH, WC
    HIRSCHGINSBERG, C
    STASS, S
    KANTARJIAN, H
    KEATING, MJ
    BLOOD, 1992, 80 (01) : 29 - 36
  • [50] HETEROGENOUS PROLIFERATIVE RESPONSE OF B-CHRONIC LYMPHOCYTIC-LEUKEMIA (B-CLL) CELLS TO DIFFERENT ACTIVATION SIGNALS AND IL-2
    VECCHI, A
    LONGO, R
    MESSORA, C
    SACCHI, S
    EXPERIMENTAL HEMATOLOGY, 1991, 19 (06) : 542 - 542
12345